As CF treatment duration extends, registry-based analyses will need to track pathogen-specific trends and long-term disease ...

Johnson & Johnson's Tremfya is the first IL-23 inhibitor to gain FDA approval in a paediatric population for plaque psoriasis ...

China’s National Medical Products Administration (NMPA) has granted approval for four-weekly intravenous (IV) maintenance ...

Oral liquid drugs play a vital role for patients who have difficulty swallowing tablets and for those requiring personalised ...

MasterControl research shows 40% of advanced therapy executives aren't confident they can meet CGT demand over the next three ...

More than two-thirds – 67% - of first responders organisations have deployed new cybersecurity protections in the last 12 ...

The US FDA has expanded the approval of Regeneron Pharmaceuticals' fully human monoclonal antibody, Evkeeza (evinacumab-dgnb) ...

AstraZeneca has launched an online direct-to-consumer (DTC) medicine platform in the US, joining a growing list of companies ...

Lithuania is rapidly growing as a leading force in the European life sciences scene, with over 400 life sciences companies in ...

The 100% rate on imported, branded pharma products will not apply to drugmakers constructing manufacturing facilities in the ...

Mérieux Equity Partners has outlined its approach to investing in Lithuania and wider Europe, highlighting a particular focus ...

Synaffix has entered a licensing agreement with South Korean biopharmaceutical firm Qurient to develop a dual-payload ADC.